SCHEMBL30948974

SCHEMBL30948974

Cc1cccc(N[C@@H]2CN(C(=O)OCc3ccccc3)CC23CC3)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GRIN2B Q13224 3/20 0.41
GBA1 P04062 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
RORC P51449 2/20 0.39
CYP2C19 P33261 1/20 0.39
ENPP2 Q13822 1/20 0.39
ATXN2 Q99700 1/20 0.39
ACACB O00763 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HTT P42858 1/20 0.38
F13A1 P00488 1/20 0.38
TGM2 P21980 1/20 0.38
TGM1 P22735 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31634701 1.00 GRM5 (0.44) GRM5CYP1A2CYP3A4GRIN2BGBA1
SCHEMBL31634718 0.86 RAB9A (0.44) GRIN2BSMN1; SMN2NPC1RAB9ARORC
SCHEMBL30948981 0.86 RAB9A (0.44) GRIN2BSMN1; SMN2NPC1RAB9ARORC
SCHEMBL30210344 0.81 SMN1; SMN2 (0.48) GRIN2BSMN1; SMN2NPC1RAB9ARORC
SCHEMBL30948984 0.81 NR1H2 (0.46) GRIN2BSMN1; SMN2NPC1RAB9ARORC
SCHEMBL34473906 0.79 SMN1; SMN2 (0.46) GRIN2BSMN1; SMN2NPC1RAB9ARORC
SCHEMBL31634669 0.77 RORC (0.35) GRIN2BSMN1; SMN2NPC1RAB9ARORC
SCHEMBL30948971 0.77 RORC (0.35) GRIN2BSMN1; SMN2NPC1RAB9ARORC
SCHEMBL29944809 0.75 ENPP2 (0.37) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL31634703 0.75 PDE4B (0.47) SMN1; SMN2NPC1RAB9ARORCCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024104452-A1 MC4R ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL USE THEREOF 长春金赛药业有限责任公司 2024-05-23 WO disclosed